Drug-coated angioplasty balloons could address DES (drug-eluting stent) safety concerns
This article was originally published in Clinica
Putting a drug coating on an angioplasty balloon is holding out promise as an alternative way of preventing restenosis - the renarrowing of the coronary arteries - after the procedure. Evidence presented at the annual Transcatheter Cardiovascular Therapeutics (TCT) symposium in Washington this week has led its researchers to predict that the technology could eventually replace stents altogether.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.